High-dose treatment with autologous stem cell transplantation in multiple myeloma : Past, present, and futureBJÖRKSTRAND, Bo; GAHRTON, Gösta.Seminars in hematology. 2007, Vol 44, Num 4, pp 227-233, issn 0037-1963, 7 p.Article

Opinion paper on the current status of the regulation of gene therapy in EuropeCOHEN-HAGUENAUER, Odile; ROSENTHAL, Felicia; THIELEMANS, Kris et al.Human gene therapy. 2002, Vol 13, Num 17, pp 2085-2110, issn 1043-0342, 26 p.Article

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma : an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMTCRAWLEY, Charles; LALANCETTE, Marc; SUREDA, Anna et al.Blood. 2005, Vol 105, Num 11, pp 4532-4539, issn 0006-4971, 8 p.Article

Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14KAPANADZE, Bagrat; MAKEEVA, Natalia; JANSSON, Monika et al.Genomics (San Diego, Calif.). 2000, Vol 70, Num 3, pp 327-334, issn 0888-7543Article

Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationGARDERET, Laurent; IACOBELLI, Simona; MILONE, Giuseppe et al.Journal of clinical oncology. 2012, Vol 30, Num 20, pp 2475-2482, issn 0732-183X, 8 p.Article

Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation: A prospective multicenter phase II study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)KRÖGER, Nicolaus; SHIMONI, Avichai; MORRIS, Curly et al.British journal of haematology. 2010, Vol 148, Num 2, pp 323-331, issn 0007-1048, 9 p.Article

Proximal promoter of the murine syndecan-1 gene is not sufficient for the developmental pattern of syndecan expression in B lineage cellsVOLPE, Carmelo P; LUNDGREN, Anna; AINTS, Alar et al.American journal of hematology. 2001, Vol 67, Num 1, pp 20-26, issn 0361-8609Article

International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantationCAVO, Michele; VINCENT RAJKUMAR, S; SONNEVELD, Pieter et al.Blood. 2011, Vol 117, Num 23, pp 6063-6073, issn 0006-4971, 11 p.Article

TK.007: A Novel, Codon-Optimized HSVtk(A168H) Mutant for Suicide Gene TherapyPREUSS, Ellen; TRESCHOW, Alexandra; FEHSE, Boris et al.Human gene therapy. 2010, Vol 21, Num 8, pp 929-941, issn 1043-0342, 13 p.Article

Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis : a report from the European Group for Blood and Marrow Transplantation. CommentaryGERTZ, Morie A; SCHÖNLAND, Stefan O; GROMMISCH, Leanthe et al.Blood. 2006, Vol 107, Num 6, issn 0006-4971, 2213-2214,2578-2584 [9 p.]Article

Disruption of a novel ectodermal neural cortex 1 antisense gene, ENC-1AS and identification of ENC-1 overexpression in hairy cell leukemiaHAMMARSUND, Marianne; LERNER, Mikael; CORCORAN, Martin et al.Human molecular genetics (Print). 2004, Vol 13, Num 23, pp 2925-2936, issn 0964-6906, 12 p.Article

Efficacy and outcome of autologous transplantation in rare myelomasMORRIS, Curly; DRAKE, Mary; NIEDERWIESER, Dietger et al.Haematologica (Roma). 2010, Vol 95, Num 12, pp 2126-2133, issn 0390-6078, 8 p.Article

Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection : long term follow-up of an EBMT phase III randomized studyBOURHIS, Jean-Henri; BOUKO, Yasmina; BJORKSTRAND, Bo et al.Haematologica (Roma). 2007, Vol 92, Num 8, pp 1083-1090, issn 0390-6078, 8 p.Article

Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myelomaCORRADINI, Paolo; CAVO, Michele; RUSSELL, Nigel et al.Blood. 2003, Vol 102, Num 5, pp 1927-1929, issn 0006-4971, 3 p.Article